Sun Pharma is an international, integrated, speciality pharmaceutical company founded in 1983. It operates manufacturing units for Active Pharmaceutical Ingredients (API) and Finished Dosage Forms (FDF) across India, the USA, Latin America, and Europe. The company is engaged in the manufacture and marketing of a wide array of pharmaceutical formulations, offering both branded generics and generics in India, the US, and various other global markets. Sun Pharma is supported by two state-of-the-art R&D centres housing a team of over 600 scientists, focusing on projects in chemical synthesis, clinical research, and formulation development. The company excels in niche therapy areas and possesses strong capabilities in product development, process chemistry, and manufacturing.

Services include:
– Active Pharmaceutical Ingredient (API) manufacturing
– Finished Dosage Form (FDF) manufacturing
– Contract Manufacturing Organisation (CMO) services
– Contract Development and Manufacturing Organisation (CDMO) services
– Aseptic liquid and lyophilized fill and finish
– Product and process development
– Analytical method development
– Commercial-scale parenteral fill and finish
– Quality control and release
– Stability testing

Sun Pharma continues to be a significant player in the pharmaceutical industry, committed to innovation and quality in its offerings. For more information, please visit sunpharma.com.